酸盐对喘和慢性阻塞性肺病的影响:基于网络毒理学和分子对接的综合分析
Ren Li1,2,3, Bingqing Zheng1,2,3, Yuqiong Zhang1,2,3
1Department of Environmental Health, School of Public Health, Shanxi Medical University, Taiyuan, China.
Frontiers in pharmacology
|March 31, 2025
概括
酸盐 (PAE) 与喘和COPD有关. 这项研究揭示了这些增塑剂如何通过影响PTGS2,MMP9和CASP3等关键基因影响肺部疾病,为公众健康提供了洞察力.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 分子生物学分子生物学
背景情况:
- 酸盐 (PAE) 是聚乙烯 (PVC) 产品中常见的增塑剂.
- 新兴研究将PAE暴露与喘和慢性阻塞性肺病 (COPD) 的发展和进展联系在一起.
- 了解PAE毒性的机制对于公共卫生至关重要.
研究的目的:
- 系统地研究七种常见的甲酸盐对喘和COPD病变的作用.
- 通过网络毒理学来识别受甲酸盐暴露影响的关键基因和生物通路.
- 为了阐明底层的分子机制甲酸诱导的肺部疾病.
主要方法:
- 采用了网络毒理学和分子对接技术.
- 来自多个数据库的综合数据,以识别与酸盐相关的基因.
- 进行功能丰富分析和分子对接,以了解病原性作用.
主要成果:
- 酸盐调节关键基因 (例如,PTGS2,MMP9,CASP3),参与亡和喘和COPD的免疫反应.
- 鉴定了因酸盐暴露而导致的炎症相关基因和信号通路中的新型调节模式.
- 分子对接证实了酸盐和基因之间的稳定相互作用,提供了机械的见解.
结论:
- 这项研究证实了七种甲酸盐对喘和COPD的有害影响.
- 建立了酸盐与疾病相关基因之间的新联系,突出了它们作为环境毒素的作用.
- 调查结果支持需要加强风险评估,公共卫生政策和关于甲酸盐暴露的法规.
更多相关视频
相关概念视频
Types of Toxins
1.6K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
263
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
263
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Antiasthma Drugs: Leukotriene Modifiers
180
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
180


